BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trebbien R, Pedersen SS, Vorborg K, Franck KT, Fischer TK. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014. Euro Surveill 2017;22:30445. [PMID: 28128091 DOI: 10.2807/1560-7917.ES.2017.22.3.30445] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Takashita E, Fujisaki S, Yokoyama M, Shirakura M, Morita H, Nakamura K, Kishida N, Kuwahara T, Sato H, Doi I, Sato Y, Takao S, Shimazu Y, Shimomura T, Ito T, Watanabe S, Odagiri T, The Influenza Virus Surveillance Group Of Japan. In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients. Pathogens 2020;9:E725. [PMID: 32887429 DOI: 10.3390/pathogens9090725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nie C, Stadtmüller M, Parshad B, Wallert M, Ahmadi V, Kerkhoff Y, Bhatia S, Block S, Cheng C, Wolff T, Haag R. Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors. Sci Adv 2021;7:eabd3803. [PMID: 33523846 DOI: 10.1126/sciadv.abd3803] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
3 Nissen JN, George SJ, Hjulsager CK, Krog JS, Nielsen XC, Madsen TV, Andersen KM, Krause TG, Vestergaard LS, Larsen LE, Trebbien R. Reassortant Influenza A(H1N1)pdm09 Virus in Elderly Woman, Denmark, January 2021. Emerg Infect Dis 2021;27:3202-5. [PMID: 34808097 DOI: 10.3201/eid2712.211361] [Reference Citation Analysis]
4 Hu Y, Zhang J, Musharrafieh RG, Ma C, Hau R, Wang J. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Antiviral Res 2017;145:103-13. [PMID: 28778830 DOI: 10.1016/j.antiviral.2017.07.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
5 Trebbien R, Koch A, Nielsen L, Kur DK, Westerström P, Krause TG. A case of reassortant seasonal influenza A(H1N2) virus, Denmark, April 2019. Euro Surveill 2019;24. [PMID: 31290388 DOI: 10.2807/1560-7917.ES.2019.24.27.1900406] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang J, Zhao L, Li R, Yan Y, Yin J, Dai Q, Guo X, Li W, Li Y, Liu M, Ren X, Yang X, Hu H, Zhong W, Cao R, Li S. In vitro and in vivo antiviral activity of Maqian (Zanthoxylum myriacanthum var. pubescens) essential oil and its major constituents against strains of influenza virus. Industrial Crops and Products 2022;177:114524. [DOI: 10.1016/j.indcrop.2022.114524] [Reference Citation Analysis]
7 Schloer S, Goretzko J, Rescher U. Repurposing Antifungals for Host-Directed Antiviral Therapy? Pharmaceuticals 2022;15:212. [DOI: 10.3390/ph15020212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kim HM, Lee N, Kim MS, Kang C, Chung YS. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea. Virol J 2020;17:94. [PMID: 32631440 DOI: 10.1186/s12985-020-01375-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Checkmahomed L, Padey B, Pizzorno A, Terrier O, Rosa-Calatrava M, Abed Y, Baz M, Boivin G. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses. Viruses 2020;12:E1139. [PMID: 33049959 DOI: 10.3390/v12101139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Gyrdymova YV, Sinegubova EO, Muryleva AS, Zarubaev VV, Rubtsova SA. Anti-Influenza Activity of Several Caryophyllane Hiosesquiterpenoids. Chem Nat Compd 2019;55:1179-81. [DOI: 10.1007/s10600-019-02928-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Torti C, Mazzitelli M, Longhini F, Garofalo E, Bruni A, Giancotti A, Barreca GS, Quirino A, Liberto MC, Serapide F, Matera G, Trecarichi EM, Navalesi P; IMAGES (Integrated MAnaGEment of Sepsis) Group. Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. BMC Infect Dis 2019;19:858. [PMID: 31619209 DOI: 10.1186/s12879-019-4530-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Borges V, Pinheiro M, Pechirra P, Guiomar R, Gomes JP. INSaFLU: an automated open web-based bioinformatics suite "from-reads" for influenza whole-genome-sequencing-based surveillance. Genome Med 2018;10:46. [PMID: 29954441 DOI: 10.1186/s13073-018-0555-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
13 Hong EH, Song JH, Kim SR, Cho J, Jeong B, Yang H, Jeong JH, Ahn JH, Jeong H, Kim SE, Chang SY, Ko HJ. Morin Hydrate Inhibits Influenza Virus entry into Host Cells and Has Anti-inflammatory Effect in Influenza-infected Mice. Immune Netw 2020;20:e32. [PMID: 32895619 DOI: 10.4110/in.2020.20.e32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]